케어젠
33,300KRWMarket close of 10/27 (Tue)
Down -0.60%-200KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)34,350KRWUp +3.15%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 33,800
- High
- 35,050
- Low
- 33,050
- Day range
- Day range low 33,050 high 35,050, open 33,800, close 33,300, previous close 33,500
- Volume
- 8×10K shares
- 2.6B KRW 1.01× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
0%1-year close range 33,300 to 150,100 won, 0% up from the low
0% of the way up from the lowest close in 1 year (252 sessions) · -77.8% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27Points to check
- Recent filingsnot verifiedCould not read filing data, so not verified
- Daily moveusual range-0.60%-0.60%, 0.2× the usual (20-session average ±3.42%)That day -0.60% · usual ±3.42% · large-move threshold ±6.8%
- Trading valueusual range1.0×2.6B KRW, 1.0× the 20-session average1.01× the 20-session average · check threshold 3×
The other 2 are within the usual range
- EarningsOperating income, 8 quarters
- Foreign & institutional+2.6B KRWusual range
See the full check report
Same sector · 제약
Down -2.22%· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +0.6% | Down -5.37% | 124.5B KRW |
| 셀트리온 | Close over the last 20 sessions +6.3% | Down -0.74% | 82.4B KRW |
| 지투지바이오 | Close over the last 20 sessions +22.2% | Down -13.38% | 46.9B KRW |
| 한미약품 | Close over the last 20 sessions -32.6% | Down -0.57% | 25.5B KRW |
| 에스티팜 | Close over the last 20 sessions -11.9% | Down -9.15% | 21.4B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 19 days
- Next data 10/29 (Thu) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.